NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Lysogene S.A (PA: LYS)

 
LYS Technical Analysis
5
As on 7th Jul 2023 LYS STOCK Price closed @ 0.28 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.99 & Strong Sell for SHORT-TERM with Stoploss of 1.80 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

LYSSTOCK Price

Open 0.28 Change Price %
High 0.28 1 Day 0.00 0.00
Low 0.28 1 Week 0.00 0.00
Close 0.28 1 Month 0.00 0.00
Volume N/A 1 Year -1.49 -84.18
52 Week High 2.09 | 52 Week Low 0.23
 
PA France Most Active Stocks
ALALO 0.00 %
ALEUP 0.01 %
ALNEV 0.00 %
FTI 5.91 -1.66%
ETL 3.71 30.63%
VIEDS 0.72 4.35%
ALVER 0.00 %
ALRPD 0.01 0.00%
ENGI 19.55 0.15%
VIV 2.88 1.05%
 
PA France Top Gainers Stocks
ETL 3.71 30.63%
ETL 3.71 30.63%
PRC 4.89 13.19%
PRC 4.89 13.19%
ALCHI 0.09 12.50%
ALTHE 0.31 10.71%
ALTRO 6.70 9.84%
ALROC 0.35 9.38%
ALRIB 3.27 9.36%
XIL 2.57 8.90%
 
PA France Top Losers Stocks
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
GNRO 0.06 -14.29%
ORP 7.90 -12.03%
MLMON 0.88 -12.00%
ALINV 1.06 -11.67%
MLCLP 0.69 -11.54%
ALBLU 0.54 -10.00%
ALMET 2.68 -9.46%
 
 
LYS
Daily Charts
LYS
Intraday Charts
Whats New @
Bazaartrend
LYS
Free Analysis
 
LYS Important Levels Intraday
RESISTANCE0.28
RESISTANCE0.28
RESISTANCE0.28
RESISTANCE0.28
RESISTANCE0.28
RESISTANCE0.28
RESISTANCE0.28
RESISTANCE0.28
 
LYS Forecast June 2025
4th UP Forecast1.51
3rd UP Forecast1.12
2nd UP Forecast0.87
1st UP Forecast0.63
1st DOWN Forecast-0.07
2nd DOWN Forecast-0.31
3rd DOWN Forecast-0.56
4th DOWN Forecast-0.95
 
LYS Weekly Forecast
4th UP Forecast0.78
3rd UP Forecast0.62
2nd UP Forecast0.52
1st UP Forecast0.42
1st DOWN Forecast0.14
2nd DOWN Forecast0.04
3rd DOWN Forecast-0.06
4th DOWN Forecast-0.22
 
LYS Forecast2025
4th UP Forecast3.98
3rd UP Forecast2.79
2nd UP Forecast2.06
1st UP Forecast1.33
1st DOWN Forecast-0.77
2nd DOWN Forecast-1.5
3rd DOWN Forecast-2.23
4th DOWN Forecast-3.42
 
 
LYS Other Details
Segment EQ
Market Capital 36198612.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
LYS Address
LYS
 
LYS Latest News
 
Your Comments and Response on Lysogene S.A
 
LYS Business Profile
Lysogene S.A. engages in the research and clinical development of gene therapy for neurodegenerative disorders. Its clinical programs include LYS-SAF302, which is in Phase II/III clinical trial for the treatment of mucopolysaccharidosis type IIIA; and LYS-GM101 that is in Phase I/II trial for the treatment of GM1 gangliosidosis. The company has a collaborative research collaboration with the Weizmann Institute of Science for developing a novel AAV gene therapy approach for neuronopathic gaucher disease, parkinson disease, and other diseases. Lysogene S.A. was founded in 2009 and is based in Neuilly-sur-Seine, France. Address: 18-20 rue Jacques Dulud, Neuilly-sur-Seine, France, 92200
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service